Business Wire

$31,000 Mutant Ape NFT Awarded to Lucky Winner of MetaWin Competition

Share

Innovative web3 company MetaWin has just closed its biggest competition yet, which has seen one lucky winner add an incredibly rare Mutant Ape NFT worth over $30,000 to their collection.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220912005563/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Mutant Ape Yacht Club (Graphic: Business Wire)

The prize draw, held on MetaWin.com, saw thousands of new entries flooding in over the final 48-hour countdown before the winner was revealed. Several participants entered over 100 times in one go in a last-minute frenzy to up their chances of winning.

The final minutes before the big winner reveal was hosted live on Instagram with peruvianprincess.eth, who shared the flurry of entries that flooded in as the clock counted down the final seconds.

After a nail-biting wait as the winner was randomly selected, the lucky web3 user was revealed to be mjouan. This NFT fan has only entered four competitions on the site - yet they have now landed their first prize, a high-value rare Mutant Ape worth over $30,000.

Mutant Ape Yacht Club 599 is a highly sought-after NFT, and for good reason. This stunning rare artwork features a number of traits held by just a tiny percentage of the collection, most notably its multicolored grin which only 1% possess.

Its value has soared in recent months - for example, it was purchased by MetaWin for 18.39ETH a week ago but since then its value has risen to 21.85ETH, or over $38,000 - making this asset an impressive investment for any NFT fan.

MetaWin.com offers anyone the chance to start winning in Web3. By connecting their MetaMask wallet to the platform free of charge, they can browse competitions for numerous NFTs from notable collections such as Moonbirds, BAYC and Genuine Undead.

Competition entries or sweeps are available free, and the platform is fully transparent - anyone can view the unique blockchain technology facilitating the transfer of prizes to each winner, along with information about how many entries a competition has and more.

Plus, MetaWin offers entry bundles where participants can buy multiple entries to competitions and save on gas fees. To find out more and join the community, head over to MetaWin.com.

About MetaWin

MetaWin is an entrepreneurial, Web3 company founded on the belief that smart contract tech is set for mass adoption and will form an important part of our everyday lives in the future.

The company’s goal is to combine its business knowledge and digital advertising expertise with ideas around smart contracts and blockchain technology. They are focused on building exciting products which provide real utility to their end users.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Imogen Groome
igroome@metawin.inc
+44 7961 231756

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station9.12.2022 20:04:00 CET | Press release

RevBio, Inc., announced that anexperiment to study Tetranite®, the company’s regenerative bone adhesive biomaterial, has successfully been initiated onboard the International Space Station (ISS). On Saturday, November 26, 2022, the study materials were launched to the space station on SpaceX’s 26th Commercial Resupply Services (SpaceX CRS-26) mission, sponsored by the ISS National Laboratory. This in vivo research, which will be conducted over the next two months on the ISS, will examine the biomaterial’s ability to regenerate bone when used in a microgravity environment where bone growing conditions and the ability to regenerate new bone tissue is significantly compromised. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221201005635/en/ RevBio Launches an Experiment for its Regenerative Biomaterial on the International Space Station. This Experiment will Examine TETRANITE’S Ability to Regenerate Bone under the Condition of

Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials9.12.2022 14:00:00 CET | Press release

Updated results from the TROPION-PanTumor01 phase 1 trial showed datopotamab deruxtecan (Dato-DXd) continued to demonstrate encouraging responses in patients with heavily pretreated metastatic triple negative breast cancer (TNBC) and disease progression following standard treatment. Results were presented today as a poster presentation (Abstract #P6-10-03) at the 2022 San Antonio Breast Cancer Symposium (#SABCS22). Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) being jointly developed by Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN). Approximately 15% of breast cancers are considered triple negative and are associated with higher disease recurrence and worse prognosis compared to other breast cancer subtypes.1,2 It is estimated that only 12% of patients with metastatic TNBC survive five years after diagnosis and median overall survival is between 12 to 18 months.1,3 In the TNBC cohort of TROPION-PanTumor01 (n=44)

Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases9.12.2022 14:00:00 CET | Press release

Takeda(TSE:4502/NYSE:TAK) today announced that it will present 15 company-sponsored abstracts at the 64th American Society of Hematology (ASH) Annual Meeting being held December 10-13, 2022 in New Orleans. Takeda’s latest research focuses on improving long-term outcomes for patients with hematologic diseases. Takeda’s presentations will include oral sessions detailing a three-year update of the Phase 3 OPTIC trial demonstrating the efficacy and safety of ICLUSIG® (ponatinib) in patients with resistant chronic-phase chronic myeloid leukemia (CP-CML), and results from a first-in-human Phase 1/2 study evaluating modakafusp alfa (TAK-573) in patients with relapsed / refractory multiple myeloma. “Our latest research is focused on investigating novel mechanisms of action, as well as optimizing approved treatments to improve long-term outcomes and more deeply understand and address unmet needs for patients across a range of hematologic diseases,” said Awny Farajallah, M.D., Head of Global Med

Tecnotree Advances to Acquire Top AIML Platform - CognitiveScale in North America to further Enhance 5G Use case Penetration9.12.2022 13:23:00 CET | Press release

Tecnotree is a market leader in 5G digital Business Support Systems (BSS), with AI/ML capabilities and multi-cloud extensibility. Tecnotree’s global footprint with over 90 Telecom customers in 70 countries around the world, supports ecosystems of over 1 billion subscribers. Tecnotree is the first Digital Platform Service provider to be Platinum Badge Certified by TM Forum for Real-world Open API standards. The company also provides B2B2X partner ecosystem and fintech services for monetization beyond connectivity across gaming, healthcare, education, and banking. Tecnotree has been recognized by Gartner for revenue management and monetization as well as for customer experience management solutions and enjoys the position of a leading stock on the Helsinki Nasdaq since 2020. CognitiveScale (CS) is United States based pioneer in the space of AI Engineering and provides solutions for scalable enterprise AI development and deployment. CognitiveScale is backed by over 100 granted AI patents

Another Sustainability Award for NTHU9.12.2022 10:00:00 CET | Press release

National Tsing Hua University (NTHU) in Taiwan has been awarded the Taiwan University Sustainability Award for the second year in a row! The Award was announced at the 15th Taiwan Corporate Sustainability Awards (TCSA) recently held by the Taiwan Institute for Sustainable Energy (TAISE). Standing out amongst the 47 participating universities, NTHU was ranked first in the comprehensive evaluation, and in the individual competitions received the University Sustainability Report Gold Award. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221209005001/en/ NTHU president W. John Kao (right) accepting the Taiwan University Sustainability Award from You Si-kun, president of the Legislative Yuan. (Photo: National Tsing Hua University) The judges cited the exemplary way in which NTHU has adopted an innovative approach to integrating classroom learning, campus activities and social service, thereby enriching students’ education and cre